Literature DB >> 6960877

Reactive arthritis associated with Clostridium difficile.

J McCluskey, T V Riley, E T Owen, D R Langlands.   

Abstract

A case of reactive arthritis in a patient with a previously documented history of Reiter's syndrome is described. The precipitating agent appears to have been Clostridium difficile. High levels of toxin were demonstrable in the faeces and neutralising antitoxin was detected in the patient's serum but not synovial fluid. Resolution of the polyarthropathy was slow despite successful eradication of the C. difficile with a course of vancomycin.

Entities:  

Mesh:

Year:  1982        PMID: 6960877     DOI: 10.1111/j.1445-5994.1982.tb03841.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  6 in total

Review 1.  Clostridium difficile toxin-induced reactive arthritis in a patient with chronic Reiter's syndrome.

Authors:  A Cope; J Anderson; E Wilkins
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

2.  Clostridium difficile Colitis Leading to Reactive Arthritis: A Rare Complication Associated With a Common Disease.

Authors:  Asghar Marwat; Hassan Mehmood; Ali Hussain; Muzammil Khan; Asad Ullah; Medha Joshi
Journal:  J Investig Med High Impact Case Rep       Date:  2018-03-30

3.  Reactive arthritis induced by Clostridium difficile.

Authors:  J L Boice
Journal:  West J Med       Date:  1994-02

4.  Clostridium difficile: an under-recognized cause of reactive arthritis?

Authors:  Julius Birnbaum; John G Bartlett; Allan C Gelber
Journal:  Clin Rheumatol       Date:  2007-09-28       Impact factor: 2.980

5.  A case of reactive arthritis due to Clostridium difficile colitis.

Authors:  Alex C Essenmacher; Nazish Khurram; Gregory T Bismack
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-02-17

6.  A Case Report and Review of the Literature: Reactive Arthritis Caused by Clostridioides difficile ribotype 027.

Authors:  Ortrud Zimmermann; Heinrich Köchel; Wolfgang Bohne; Beatrix Pollok-Kopp; Peter Passenberg; Uwe Groß
Journal:  Front Microbiol       Date:  2022-02-16       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.